Phosphatidylcholine transfer protein inhibitor-1
Phosphatidylcholine transfer protein inhibitor-1 (Answer 37 in Patent) is a phosphatidylcholine transfer protein (PC-TP) inhibitor. Phosphatidylcholine transfer protein inhibitor-1 can be used for research of PC-TP related disease such as obesity[1].
Product Specifications
CAS Number
[379723-99-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/phosphatidylcholine-transfer-protein-inhibitor-1.html
Purity
98.01
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(C1=CC=C(C=C1)F)NC(NC2=CC=C(C)C(S(=O)(NC3=CC(Cl)=CC=C3)=O)=C2)=S
Molecular Formula
C21H17ClFN3O3S2
Molecular Weight
477.96
Precautions
H302, H315, H319
References & Citations
[1]David Cohen, et al. Phosphatidylcholine transfer protein inhibitors. Patent. WO2011022393.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Human Protocadherin gamma C3 Alexa Fluor 750 MAb (926518)
P15RS (RPRD1A, Regulation of Nuclear Pre-mRNA Domain-containing Protein 1A, Cyclin-dependent Kinase Inhibitor 2B-related Protein, p15INK4B-related Protein, FLJ10656, HsT3101, MGC19513) (FITC)
EVI2B (Protein EVI2B, Ecotropic Viral Integration Site 2B Protein Homolog, EVI-2B, CD361, EVDB) (MaxLight 490)
EVI2B (Protein EVI2B, Ecotropic Viral Integration Site 2B Protein Homolog, EVI-2B, CD361, EVDB) (MaxLight 490)